Cancer

Items 21-30 of 47

per page
Set Descending Direction
  1. Concanamycin C (high purity)
    CAS  81552-34-3
    BVT-0254
    BVT-0254-C02525 µg
    CHF 95.00
    BVT-0254-C100100 µg
    CHF 205.00
    BVT-0254-C500500 µg
    CHF 575.00
    BVT-0254-M0011 mg
    CHF 815.00
    Concanamycin C (high purity)
  2. Epoxomicin
    CAS  134381-21-8
    AG-CN2-0422
    AG-CN2-0422-C05050 µg
    CHF 90.00
    AG-CN2-0422-C100100 µg
    CHF 150.00
    AG-CN2-0422-C250250 µg
    CHF 290.00
    AG-CN2-0422-C500500 µg
    CHF 450.00
    Epoxomicin
  3. Fc (human):Grancalcin (human) (rec.)
    AG-40B-0242
    AG-40B-0242-C05050 µg
    CHF 440.00
  4. GITR (human):Fc (human) (rec.)
    AG-40B-0028
    AG-40B-0028-C05050 µg
    CHF 385.00
    AG-40B-0028-30503 x 50 µg
    CHF 770.00
  5. GITR (mouse):Fc (human) (rec.)
    AG-40B-0002
    AG-40B-0002-C05050 µg
    CHF 350.00
    AG-40B-0002-30503 x 50 µg
    CHF 695.00
  6. GITRL, Soluble (human) (rec.)
    CHI-AG-40A-0019
    CHI-AG-40A-0019-C05050 µg
    CHF 470.00
  7. GITRL, Soluble (human) (rec.) (His)
    AG-40A-0024T
    AG-40A-0024T-C01010 µg
    CHF 145.00
    AG-40A-0024T-C05050 µg
    CHF 420.00
  8. GITRL, Soluble (mouse) (rec.)
    AG-40A-0008
    AG-40A-0008-C05050 µg
    CHF 350.00
    GITRL, Soluble (mouse) (rec.) (Prod. No. AG-40A-0008) induced GITR-mediated NF-κB activation.  HEK293 cells were transiently transfected with 20ng of a (NF-κB)-Luc reporter, 2ng of a Renilla luciferase, and with 20ng of a GITR full lengt
  9. Lovastatin
    CAS  75330-75-5
    AG-CN2-0051
    AG-CN2-0051-M0055 mg
    CHF 25.00
    AG-CN2-0051-M02525 mg
    CHF 65.00
    Lovastatin
  10. MK-2206 dihydrochloride
    CAS  1032350-13-2
    SYN-1162
    SYN-1162-M0011 mg
    CHF 99.00
    SYN-1162-M0055 mg
    CHF 156.00
    SYN-1162-M01010 mg
    CHF 241.00
    SYN-1162-M05050 mg
    CHF 788.00
    SYN-1162-M100100 mgINQ
    MK-2206 dihydrochloride

Items 21-30 of 47

per page
Set Descending Direction
© 2017 Adipogen Life Sciences. Pictures: © 2012 Martin Oeggerli. All Rights Reserved.